They clearly show a trend in which higher receptor expression corresponds to more favorable clinical profile in patients, including lower plasma ACTH level, smaller tumor size, clinical remission after surgery and favorable features of sparsely granulated, USP8-mutated tumors. This evidence concerns the gene USP8 and neoplasm.